E

Epitopea

10 employees

Epitopea is a transatlantic cancer immunotherapeutics company.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Antigen presentation
Splicing
Oncology
Vaccines
Immuno-oncology
Therapeutics
TCR-T cells
Epigenetics
T cell biology
Bi-specifics
Life Science

Date founded

2021

Funding rounds raised

Total raised

$13M

from 4 investors over 4 rounds

E

Epitopea raised $13M on April 25, 2022

Investors: Novateur Ventures Inc., Advent Life Sciences, Cambridge Innovation Capital plc and Harrington Discovery Institute at University Hospitals

FAQ